99% Purity Letrzole Femara

<

Model NO.: Letrozoles
Trademark: XXJL
Transport Package: Can Be Packed as Requirement
Specification: USP
Origin: China
HS Code: 2942000000
Model NO.: Letrozoles
Trademark: XXJL
Transport Package: Can Be Packed as Requirement
Specification: USP
Origin: China
HS Code: 2942000000

Hot Sell for Letrzo-les Femara 


Product Description
Letrozol-e
Alias:Letrazol-e; Letrozol-e Femara
CAS No: 
Molecular formula: C17H11N5
Molecular weight: 285.3
Appearance: White power
Assay: 99%
Delivery time: 5-7 days 
Minimum order: 10g
Supply ability: 5000kg/month
Quality standard: USP32   
Payment:Western Union and Money Gram
Delivery:Within 24hours After Your Payment

Detail:
 

Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
 
Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamo-f. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
 
Femara is used for the treatment of post-menopause breast cancer. 
Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic ster-oid water-retention, acne and gynocomastia. It will also raise t levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system. 




Specifications:
 
Tests Specifications Results
Appearance White or off-white crystaline powder White
Crystalline powder
Solubility
 
Soluble in Chloroform;
Soluble in ethanol when heated
Conform
ldentification (1)Maximum absorption in wavelength of 240 nm
Minimum absorption in wavelength of 215 nm
Conform
Conform
(2)Infrared spectrum should be in accordance the dominant peak of contrast In accordance with the dominant peak of contrast
Melting points 182ºC-184ºC 182ºC
Related substances ≤0.5% 0.3%
Single impurity ≤0.3% 0.2%
Loss on drying ≤1.0% 0.8%
[Assay]C17H11N5
(On anhydrous basis)
≥98.0% 99.2%

 
 
 

Hot Sell for Letrzo-les Femara 


Product Description
Letrozol-e
Alias:Letrazol-e; Letrozol-e Femara
CAS No: 
Molecular formula: C17H11N5
Molecular weight: 285.3
Appearance: White power
Assay: 99%
Delivery time: 5-7 days 
Minimum order: 10g
Supply ability: 5000kg/month
Quality standard: USP32   
Payment:Western Union and Money Gram
Delivery:Within 24hours After Your Payment

Detail:
 

Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
 
Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamo-f. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
 
Femara is used for the treatment of post-menopause breast cancer. 
Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic ster-oid water-retention, acne and gynocomastia. It will also raise t levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system. 




Specifications:
 
Tests Specifications Results
Appearance White or off-white crystaline powder White
Crystalline powder
Solubility
 
Soluble in Chloroform;
Soluble in ethanol when heated
Conform
ldentification (1)Maximum absorption in wavelength of 240 nm
Minimum absorption in wavelength of 215 nm
Conform
Conform
(2)Infrared spectrum should be in accordance the dominant peak of contrast In accordance with the dominant peak of contrast
Melting points 182ºC-184ºC 182ºC
Related substances ≤0.5% 0.3%
Single impurity ≤0.3% 0.2%
Loss on drying ≤1.0% 0.8%
[Assay]C17H11N5
(On anhydrous basis)
≥98.0% 99.2%